We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sanofi | TG:SNW | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.88 | 0.96% | 92.57 | 92.50 | 92.63 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
93.28 | 91.65 | 91.98 | 3,362 | 22:50:06 |
Date | Time | Source | Headline |
---|---|---|---|
20/11/2024 | 13:11 | UKREG | Sanofi: Informations relatives au nombre de droits de vote et d'actions -.. |
20/11/2024 | 13:11 | UKREG | Sanofi: Information concerning the total number of voting rights and shares.. |
15/11/2024 | 06:00 | UKREG | Communiqué de presse : La FDA a accepté l’examen de la sBLA pour le.. |
15/11/2024 | 06:00 | UKREG | Press Release: Dupixent sBLA accepted for FDA review for the treatment of.. |
14/11/2024 | 16:42 | UKREG | Communiqué de presse : Sarclisa : approbation recommandée par le CHMP dans.. |
14/11/2024 | 16:42 | UKREG | Press Release: Sarclisa recommended for EU approval by the CHMP to treat.. |
06/11/2024 | 06:00 | UKREG | Communiqué de presse : Dupixent, premier et seul médicament approuvé dans.. |
06/11/2024 | 06:00 | UKREG | Press Release: Dupixent approved in the EU as the first and only medicine.. |
25/10/2024 | 05:30 | UKREG | Press Release: Sanofi Q3: 15.7% sales growth boosted by.. |
25/10/2024 | 05:30 | UKREG | Communiqué de presse : T3 2024 : Croissance des ventes de 15,7% soutenue.. |
1 Year Sanofi Chart |
Intraday Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions